Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2024 06:30 ET | Source: Matinas BioPharma Holdings, Inc.

Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction

BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet regarding...
October 25, 2024 11:32 ET | Source: SeaStar Medical Holding Corporation

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update

Data illustrate the potential of QUELIMMUNE™️ with cost neutrality starting at 6 days of therapy and a significant reduction in total hospitalization costs in children with acute kidney injury ...
October 25, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024

Data illustrate the potential of QUELIMMUNE™️ with cost neutrality starting at 6 days of therapy and a significant reduction in total hospitalization costs in children with acute kidney injury ...
October 23, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial

DENVER, Oct. 23, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
October 22, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
October 18, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

The pace of patient enrollment has significantly accelerated following a summertime slowdown DENVER, Oct. 18, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a...
October 18, 2024 05:00 ET | Source: Private Bancorp of America, Inc.

Private Bancorp of America, Inc. Announces Record Net Income and Earnings Per Share for Third Quarter 2024

Third Quarter 2024 Highlights Record net income for the third quarter of 2024 was $9.5 million, compared to $7.8 million in the prior quarter and $8.5 million in the third...
October 17, 2024 08:00 ET | Source: ProductLife Group (PLG)

ProductLife Group (PLG) Acquires Halloran to Further Expand Its Global Reach and Capabilities to Support the Development of New Therapies

ProductLife Group (PLG) today announced the acquisition of Halloran Consulting Group, a life science consulting firm.
October 15, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week

DENVER, Oct. 15, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
October 09, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit

DENVER, Oct. 09, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...